DSM-5 Diagnosis Criteria for PMDD

Premenstrual dysphoric disorder (PMDD) is a cyclical mood disorder listed in the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5)—a standard reference clinicians use for mental health diagnoses—with symptoms that mainly build before menstruation and ease after it starts ^[1]. Beyond symptom-and-timing rules, the manual also requires prospective confirmation across two symptomatic cycles ^[2].

Criterion A: Timing

PMDD is defined largely by when symptoms appear, not only by which symptoms occur ^[3]. In the majority of menstrual cycles during the past year, at least five symptoms must be present during the final week before menstruation begins ^[4]. Those symptoms must start to improve within a few days after menstruation starts, and become minimal or absent in the week after ^[4]. Criterion A sets this timing pattern and the five-symptom count; which specific symptoms count toward that total is defined in Criteria B and C below.

For many people, severity peaks in the days just before menstruation and eases once bleeding starts, though individual timing can vary across the cycle.

Criterion B: Core Mood Symptoms

At least one core mood symptom must be present ^[5]:

• Marked mood swings or affective lability (for example, feeling suddenly sad or tearful, or more sensitive to rejection)
• Marked irritability, anger, or increased interpersonal conflicts
• Marked depressed mood, feelings of hopelessness, or self-deprecating thoughts
• Marked anxiety, tension, or feeling keyed up or on edge

Criterion C: Additional Symptoms

One or more additional symptoms must combine with Criterion B symptoms to reach five symptoms total ^[6]:

• Decreased interest in usual activities (work, school, friends, or hobbies)
• Difficulty concentrating
• Lethargy, easy fatigability, or marked lack of energy
• Marked change in appetite, overeating, or specific food cravings
• Hypersomnia or insomnia
• A sense of being overwhelmed or out of control
• Physical symptoms such as breast tenderness or swelling, joint or muscle pain, bloating, or weight gain

The symptoms in Criteria A through C must have been present in most cycles during the preceding year ^[7].

Criterion D: Severity

Symptoms must cause clinically significant distress or interfere with work, school, usual social activities, or relationships ^[8]. This impairment requirement helps separate PMDD from mild premenstrual changes that do not substantially disrupt daily life ^[9].

Criterion E: Psychiatric Exclusion

The pattern must not represent only a premenstrual worsening of another psychiatric disorder, such as major depression, panic disorder, persistent depressive disorder, or a personality disorder, although PMDD can co-occur with these conditions ^[10]. Premenstrual exacerbation (PME) refers to worsening of an existing psychiatric condition during the premenstrual phase while symptoms of that condition remain present throughout the menstrual cycle at a lower baseline level ^[11]. Telling PMDD apart from PME depends on whether symptoms clear in the follicular phase—the part of your cycle after your period ends, before ovulation—not only whether they feel worse before menstruation ^[12].

Criterion F: Prospective Confirmation

Prospective daily symptom ratings across at least two symptomatic menstrual cycles are the diagnostic gold standard ^[13]. The DSM-5 allows a provisional diagnosis before this confirmation is complete, and clinical commentary notes that prospective confirmation may use two symptomatic cycles that are not necessarily consecutive ^[14].

Retrospective screening tools such as the Premenstrual Symptoms Screening Tool (PSST) can flag concerning symptoms, but they are not a substitute for prospective daily diaries such as the Daily Record of Severity of Problems (DRSP) ^[15]. In one validation study, PSST identified PMDD in 34.6% of participants versus 3.9% with prospective DRSP ratings ^[16]. When screening for PMS or PMDD combined in that study, PSST showed high sensitivity but low specificity ^[17]—meaning many true cases were flagged, but false positives were also common.

Depression can further inflate retrospective screening: PSST over-diagnosed PMS and PMDD in people with depression but not in those without depression ^[18]. A positive screen still warrants clinical review with a qualified provider; co-occurring depression does not mean cyclical premenstrual worsening is imaginary or unworthy of assessment.

Completing two full cycles of daily ratings is demanding—only about 45% of participants in one study finished both DRSP cycles ^[19]. Partial records still have value: bring whatever tracking you have completed so a clinician can interpret the pattern alongside your history. Because retrospective screening can overestimate PMDD—especially when depression is present—prospective records reviewed with a qualified clinician are the most reliable way to confirm cyclical timing.

Criterion G: Substance and Medical Exclusion

Symptoms must not be attributable to the physiological effects of a substance, such as a drug of abuse or a medication ^[20], and must not be explained by another medical condition, such as hyperthyroidism ^[21].

Steps Toward a Professional Evaluation

Clinical assessment of PMDD typically includes daily symptom tracking across at least two menstrual cycles ^[22]. Standard prospective confirmation works best with a trackable natural menstrual cycle; pregnancy, breastfeeding, and hormonal contraception can suppress ovulation and alter cycle timing ^[23]. If your cycle is irregular or absent, discuss how to adapt tracking with your clinician. Some people find these steps helpful when preparing for an evaluation:

• Start daily tracking of mood and physical symptoms across the full menstrual cycle.
• Continue for at least two symptomatic cycles to match prospective confirmation standards.
• Note how symptoms affect work, relationships, and daily activities.
• Bring tracking records to a clinical appointment for review with a provider.
• Discuss timing and baseline symptoms openly, including whether symptoms ease between cycles, to help distinguish PMDD from premenstrual exacerbation of another condition.

Living with severe premenstrual symptoms is challenging, and those experiences deserve serious clinical attention. PMDD is a recognized medical condition—not a character flaw or lack of willpower—and accurate diagnosis supports appropriate treatment planning.